London: Italian pharmaceutical company Menarini has opened its Middle East headquarters in Dubai’s Science Park.
Specializing in pharma research and production, consumer healthcare, oncology and diagnostics, the move is part of the group’s planned expansion into the Middle East and Africa.
CEO Elsin Barker Ergan said, “This is a historic moment for us as we open our regional offices in Dubai to significantly increase our presence and portfolio in the Middle East.”
“As a 135-year-old family-owned company, we look forward to serving many more patients in the Middle East in the years to come with our unwavering commitment to quality.”
Among those present at the opening ceremony were Amin Hussein Al-Amiri, Assistant Under Secretary for Public Health Policy and Licensing in the United Arab Emirates.
Also in attendance were Italian Ambassador Nicola Lener, Menarini’s General Manager Luca Lastrucci and its regional head Basel Thaher.
Ali Al-Saeed, Director of the Pharmaceutical Services Department at the Dubai Health Authority, said: “A defining objective of Dubai 2030 is to become a global hub for knowledge-based, sustainable and innovation-focused businesses.
“As a company with long-standing roots in medical research, Menarini will be a strong contributor to this visionary strategy.”
He added: “Together, we share Dubai’s comprehensive health vision of positioning Dubai as the leading destination for healthcare knowledge, education and training.”